What is the 13F Pro Quality Score for NTRB?

13F Pro ranks NutriBand Inc. (NTRB) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View NTRB's current score at https://13fpro.ai/research/NTRB (free sign-up required for the full ranking).

Where does 13F Pro source NTRB data?

All NutriBand Inc. fundamentals and ownership data come directly from SEC EDGAR. NutriBand Inc. files with the SEC under CIK 1676047. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is NTRB in?

NutriBand Inc. (NTRB) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is NTRB research updated on 13F Pro?

NTRB's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

NutriBand Inc.(NTRB)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1676047 NTRB stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $2.1M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

NTRB Stock Analysis & AI Quality Score

AI stock analysis and institutional research for NutriBand Inc. (NTRB), a Healthcare sector company. NTRB is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $2.1m in revenue. Based on the latest XBRL financial filings (Q1 2027), NutriBand Inc. reports quarterly revenue of $433.4K, net income of $-1.2M, free cash flow of $-563.1K. Top institutional holders of NTRB by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT,, UBS Group AG, based on the most recent SEC filings. NTRB trades on the Nasdaq exchange and files with the SEC under CIK 1676047. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NTRB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NutriBand Inc. directly from SEC EDGAR.

Revenue

Q1 2027

$433.4K

Net Income

Q1 2027

$-1.2M

Free Cash Flow

Q1 2027

$-563.1K

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-2.3% YoY

$2.0MFY 2026

FY22 $1.4MFY23 $2.1MFY24 $2.1MFY26 $2.0M

Net Income

-50.0% YoY

$-8.2MFY 2026

FY22 $-6.2MFY23 $-4.5MFY24 $-5.5MFY26 $-8.2M

Operating Income

-70.7% YoY

$-8.3MFY 2026

FY22 $-6.1MFY23 $-4.5MFY24 $-4.9MFY26 $-8.3M

EPS (Diluted)

-273.9% YoY

$-2.58FY 2026

FY22 $-0.80FY23 $-0.53FY24 $-0.69FY26 $-2.58

Total Assets

+0.4% YoY

$7.5MFY 2026

FY22 $12.7MFY23 $9.5MFY24 $7.5MFY26 $7.5M

Total Debt

—FY 2026

FY22 —FY23 —FY24 $2.0MFY26 —

Op. Cash Flow

-45.6% YoY

$-5.1MFY 2026

FY22 $-2.8MFY23 $-3.0MFY24 $-3.5MFY26 $-5.1M

Metric	FY 2026	FY 2024	FY 2023	FY 2022	FY 2019	FY 2018
Revenue	$2.0M -2.3%	$2.1M +0.3%	$2.1M +46.2%	$1.4M +479.8%	$245.3K	—
Net Income	$-8.2M -50.0%	$-5.5M -22.3%	$-4.5M +27.4%	$-6.2M -85.4%	$-3.3M -24.7%	$-2.7M
Operating Income	$-8.3M -70.7%	$-4.9M -8.9%	$-4.5M +26.8%	$-6.1M -83.4%	$-3.3M -24.7%	$-2.7M
EPS (Diluted)	$-2.58 -273.9%	$-0.69 -30.2%	$-0.53 +33.8%	$-0.80	—	—
Total Assets	$7.5M +0.4%	$7.5M -20.5%	$9.5M -25.8%	$12.7M +353.8%	$2.8M +1602.6%	$164.9K
Total Debt	—	$2.0M	—	—	$0.00 -100.0%	$17.9K
Operating Cash Flow	$-5.1M -45.6%	$-3.5M -18.1%	$-3.0M -6.3%	$-2.8M -154.1%	$-1.1M -1090.5%	$-92.9K

AI Insight: NTRB Financial Trends

NutriBand is a pre-revenue company burning cash with eroding equity, signaling distress without visible path to profitability.

• Revenue collapsed from $1M in Q1–Q3 2025 to $0M in Q4 2025 and remains flat through Q2 2026.

• Operating cash burn consistent at $1–2M per quarter; net losses range $1–6M quarterly with no improvement trajectory.

• Equity declined 50% from $12M (Q3 2024) to $6M (Q2 2026), reflecting cumulative losses and shareholder capital destruction.

⚠ Equity stabilized at $6–8M range Q3 2025–Q2 2026 after steep drop; runway unclear without capital injection or revenue restart.

⚠ Q4 2025 net loss spiked to $4M despite $0M revenue; operational discipline deteriorated or one-time charges emerged.

AI Insight: NTRB Ratio Trends

NutriBand remains deeply unprofitable with deteriorating returns across all efficiency metrics; ROE swung from -58.0% in Q1 2026 to -82.9% in Q2 2026.

• ROE declined from -58.0% in Q1 2026 to -82.9% in Q2 2026, signaling worsening shareholder value destruction.

• ROA fell from -51.3% in Q1 2026 to -72.1% in Q2 2026, indicating deteriorating asset utilization.

• ROIC dropped from -61.1% in Q1 2026 to -83.8% in Q2 2026, showing accelerating capital inefficiency.

⚠ TTM ROE of -134.9% reflects cumulative trailing losses; lack of margin/profitability data limits visibility into operational recovery path.

⚠ Sequential deterioration in all available returns (Q2 2026 vs Q1 2026) suggests no stabilization or inflection underway.

Get alerted when NTRB's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for NutriBand Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of NTRB

VANGUARD CAPITAL MANAGEMENT LLC
$617.5K174,927 sh
GEODE CAPITAL MANAGEMENT, LLC
$247.3K70,053 sh
UBS Group AG
$115.3K32,664 sh
CITADEL ADVISORS LLC
$107.2K95,709 sh
VANGUARD FIDUCIARY TRUST CO
$88.6K25,111 sh
STATE STREET CORP
$88.1K24,966 sh
Clear Street Group Inc.
$69.0K61,590 sh
NORTHERN TRUST CORP
$49.2K13,945 sh
Empery Asset Management, LP
$45.0K40,218 sh
Haven Private, LLC
$40.1K11,366 sh

Fund	Value	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$617.5K	174,927
GEODE CAPITAL MANAGEMENT, LLC	$247.3K	70,053
UBS Group AG	$115.3K	32,664
CITADEL ADVISORS LLC	$107.2K	95,709
VANGUARD FIDUCIARY TRUST CO	$88.6K	25,111
STATE STREET CORP	$88.1K	24,966
Clear Street Group Inc.	$69.0K	61,590
NORTHERN TRUST CORP	$49.2K	13,945
Empery Asset Management, LP	$45.0K	40,218
Haven Private, LLC	$40.1K	11,366

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put NTRB on your watchlist

Track score changes the day NutriBand Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is NTRB a good stock to buy?

13F Pro's AI-powered analysis of NutriBand Inc. (NTRB) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NTRB are available on the NTRB stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own NTRB?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NTRB. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of NutriBand Inc.'s investment landscape.